New Drug Target For Huntington’s Disease
McMaster University researchers have first insight into how Huntington’s disease (HD) is triggered. The research is published online in the British Journal, Human Molecular Genetics.”These are exciting results by the McMaster team,” said Dr. Rémi Quirion, Scientific Director at the Canadian Institutes of Health Research, Institute of Neuroscience, Mental Health and Addiction.
